Peptides for Appetite Stimulation
Reviewed by Marcus Hopkin, PhD
Director of Research and Development, Volta Peptides
Written by Volta Peptides Editorial Team · Reviewed September 15, 2026
This guide provides a comprehensive overview of two peptides that have been investigated for their potential in stimulating appetite. The peptides are ranked based on the strength of available evidence, ranging from those with regulatory approval to those still in early stages of research. Each compound is analyzed in terms of its mechanism of action, clinical status, and safety profile, offering insights into their applicability for appetite stimulation in various contexts.
Overview
2 research peptides are currently studied for appetite stimulation. This guide ranks them by evidence strength and covers their mechanisms, safety profiles, and current clinical status.
Anamorelin — Phase III / Regulatory Approval (Japan)
Evidence Rating: B
Category: Growth Hormone Secretagogue
Anamorelin is a synthetic peptide designed to act as an agonist for the ghrelin receptor (GHS-R1a), specifically targeting cancer-related cachexia. Its formulation allows for once-daily oral intake, providing a significant advantage over endogenous ghrelin, which has a very short half-life. In 2021, anamorelin received regulatory approval in Japan for use in patients suffering from cachexia associated with non-small cell lung cancer (NSCLC), gastric, pancreatic, and colorectal cancers. This approval is notable as it positions anamorelin among a limited group of peptide-derived therapies that specifically address cachexia. Clinical trials have demonstrated its ability to increase lean body mass and stimulate appetite in affected individuals, although it remains unapproved by the FDA or EMA, highlighting the need for further studies to confirm its efficacy and safety in broader populations.
Ghrelin — Well-characterized endogenous hormone with approved analogs
Evidence Rating: B
Category: Growth Hormone / Appetite
Ghrelin is a 28-amino acid peptide hormone predominantly produced in the stomach, recognized as the primary endogenous ligand for the growth hormone secretagogue receptor (GHS-R1a). As the only known orexigenic hormone in circulation, ghrelin plays a critical role in stimulating appetite, promoting fat storage, and regulating energy metabolism between the gastrointestinal tract and the central nervous system. Its biological activity is contingent upon a specific post-translational modification known as n-octanoylation at Ser3. Research indicates that ghrelin not only stimulates the release of growth hormone but also significantly enhances appetite. Various pharmaceutical analogs, including anamorelin, have been developed to leverage ghrelin's appetite-stimulating properties, particularly in the context of cachexia. While evidence supports its role in appetite stimulation, further exploration is warranted to fully understand its potential therapeutic applications and the implications of long-term modulation of ghrelin signaling.
Shop Research Peptides
Cagrilintide 5mg
DSIP 10mg
Epithalon 10mg
GHRP-2 5mg
5mg
Quality Documentation
Review batch documentation before making research purchasing decisions. Volta pairs product education with COA literacy so researchers can evaluate purity, identity, lot details, and testing context.
Product cards on this page link to current catalog entries and available quality documentation.
Related Research News
CJC-1295 with DAC and Ipamorelin: Growth Hormone Research Guide
CJC-1295 with DAC and Ipamorelin represent key compounds in growth hormone research, targeting distinct pathways for GH and IGF-1 signaling. CJC-1295 with DAC acts as a long-acting GHRH analogue with a half-life of 5.8 to 8.1 days, while Ipamorelin functions as a selective growth hormone secretagogue via the ghrelin receptor. Together, they support studies on metabolism, recovery, and body composition.
Ipamorelin vs GHRP-2: Which Offers More Targeted GH Release?
Ipamorelin and GHRP-2 both stimulate growth hormone release via the ghrelin receptor, but Ipamorelin provides more selective action with minimal impact on other hormones like ACTH and cortisol. GHRP-2 delivers stronger GH pulses alongside broader endocrine effects. Combining them can enhance overall GH output through additive receptor stimulation.
Peptide Tools
Key research references
- Best Peptides for Anti-Aging | Research Guide
- Best Peptides for Metabolic Health | Research Guide
- Best Peptides for Weight Management | Research Guide
- Best Peptides for Body Composition | Research Guide
- Best Peptides for Reproductive Health | Research Guide
- Best Peptides for Anti-Aging & Longevity | Research Guide
- Best Peptides for Weight Loss | Research Guide
- Best Peptides for Cognitive Enhancement | Research Guide
- Retatrutide Dosing Guide | Protocols & Reconstitution
- Wound Healing Peptides | Research Compounds
- Muscle Growth Peptides | Research Compounds
- Immune Modulation Peptides | Research Compounds
Browse the research catalogue
Buying and verification
Frequently Asked Questions
Related Resources
Related Research
About the reviewer
Director of Research and Development, Volta Peptides
Marcus Hopkin, PhD, is Director of Research and Development at Volta Peptides. He has more than 12 years of analytical chemistry experience, including direct laboratory work in peptide synthesis, characterization, purity testing and stability assessment. His doctoral research at the University of Michigan examined novel peptide structures in the human proteome and their potential significance for therapeutic-peptide research. Before joining Volta Peptides he held research and development roles at Amgen and Eli Lilly and Company, and served as a lecturer at the University of Michigan.
Marcus reviewed this article for scientific and analytical accuracy on September 15, 2026. He did not write it. Technical review is internal review and is not peer review, independent third-party review or medical review.
Disclosure. Marcus Hopkin is an employee of Volta Peptides and serves as its Director of Research and Development. Volta Peptides sells research compounds related to subjects discussed in the content he writes and reviews. His reviews are internal scientific and technical review and must not be described as independent third-party review, peer review or medical review.